Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Ossiam

Ossiam reduced its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 49.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,628 shares of the company’s stock after selling 6,508 shares during the period. Ossiam’s holdings in Cardinal Health were worth $784,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in CAH. Barclays PLC boosted its holdings in Cardinal Health by 8.2% in the third quarter. Barclays PLC now owns 707,404 shares of the company’s stock valued at $78,183,000 after purchasing an additional 53,851 shares during the period. Wilmington Savings Fund Society FSB acquired a new stake in Cardinal Health in the 3rd quarter valued at about $846,000. Franklin Resources Inc. boosted its stake in shares of Cardinal Health by 6.6% in the 3rd quarter. Franklin Resources Inc. now owns 151,185 shares of the company’s stock valued at $16,918,000 after buying an additional 9,385 shares during the period. Oddo BHF Asset Management Sas acquired a new position in shares of Cardinal Health during the third quarter worth about $497,000. Finally, Copley Financial Group Inc. purchased a new stake in shares of Cardinal Health during the third quarter worth approximately $507,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Morgan Stanley lifted their price target on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research note on Friday, January 31st. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $130.00 to $144.00 in a research report on Wednesday, January 8th. JPMorgan Chase & Co. increased their target price on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Finally, Citigroup upped their price objective on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research report on Friday, January 10th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $140.86.

Cardinal Health Stock Performance

NYSE CAH opened at $131.32 on Tuesday. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $139.50. The firm has a market cap of $31.72 billion, a PE ratio of 24.50, a P/E/G ratio of 1.49 and a beta of 0.61. The firm’s fifty day moving average is $130.11 and its two-hundred day moving average is $123.47.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.54%. The ex-dividend date of this dividend was Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.